A German study by Reimer et al. reviewed 83 PTCL patients (ALK-positive ALCL excluded) who received four to six cycles of CHOP followed by autoSCT if at least a PR achieved (n = 55, 66%). This evidence concerns the gene ALK and mature T-cell and NK-cell non-Hodgkin lymphoma.